JP2023504646A5 - - Google Patents

Info

Publication number
JP2023504646A5
JP2023504646A5 JP2022532833A JP2022532833A JP2023504646A5 JP 2023504646 A5 JP2023504646 A5 JP 2023504646A5 JP 2022532833 A JP2022532833 A JP 2022532833A JP 2022532833 A JP2022532833 A JP 2022532833A JP 2023504646 A5 JP2023504646 A5 JP 2023504646A5
Authority
JP
Japan
Prior art keywords
benzothiazepine
tetrahydro
dioxide
alkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022532833A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023504646A (ja
JP7665621B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/084571 external-priority patent/WO2021110887A1/en
Publication of JP2023504646A publication Critical patent/JP2023504646A/ja
Publication of JP2023504646A5 publication Critical patent/JP2023504646A5/ja
Application granted granted Critical
Publication of JP7665621B2 publication Critical patent/JP7665621B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022532833A 2019-12-04 2020-12-04 ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 Active JP7665621B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201911049985 2019-12-04
IN201911049985 2019-12-04
PCT/EP2020/084571 WO2021110887A1 (en) 2019-12-04 2020-12-04 Benzothiazepine compounds and their use as bile acid modulators

Publications (3)

Publication Number Publication Date
JP2023504646A JP2023504646A (ja) 2023-02-06
JP2023504646A5 true JP2023504646A5 (https=) 2023-12-05
JP7665621B2 JP7665621B2 (ja) 2025-04-21

Family

ID=82196618

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022532833A Active JP7665621B2 (ja) 2019-12-04 2020-12-04 ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用

Country Status (4)

Country Link
EP (1) EP4069362A1 (https=)
JP (1) JP7665621B2 (https=)
CN (1) CN114786773B (https=)
CA (1) CA3158175A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4188541B1 (en) * 2020-08-03 2024-12-25 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9800428D0 (en) * 1998-01-10 1998-03-04 Glaxo Group Ltd Chemical compounds
EG26979A (en) * 2000-12-21 2015-03-01 Astrazeneca Ab Chemical compounds
GB0121337D0 (en) * 2001-09-04 2001-10-24 Astrazeneca Ab Chemical compounds
DK2637646T3 (en) * 2010-11-08 2016-08-29 Albireo Ab PHARMACEUTICAL COMBINATION CONTAINING AN IBAT inhibitor and a bile acid binder

Similar Documents

Publication Publication Date Title
JP2023504644A5 (https=)
JP2024520677A5 (https=)
JP2023504645A5 (https=)
JP2023504647A5 (https=)
JP2023504643A5 (https=)
JP2022519664A5 (https=)
JP2023537285A5 (https=)
JP2024500309A5 (https=)
JP2022519370A5 (https=)
FI4069360T3 (fi) Bentsotia(di)atsepiinin yhdisteet ja niiden käyttö sappihapon modulaattoreina
HRP20230039T1 (hr) Benzotiadiazepinski spojevi i njihova uporaba kao modulatora žučnih kiselina
JP7391048B2 (ja) ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
JP2021525780A5 (https=)
TWI865673B (zh) 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
JP7504110B2 (ja) ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
TWI871392B (zh) 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
JP2019504898A5 (https=)
TW202134218A (zh) 苯并噻氮呯化合物及其作為膽酸調節劑之用途
JP2021528416A (ja) オデビキシバットの結晶変態
KR102338085B1 (ko) 담즙울체성 질환의 치료 방법
TW202134221A (zh) 苯并噻二氮呯化合物及其作為膽酸調節劑之用途
JP2023504643A (ja) ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
JP2023504644A (ja) ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
JP2019504899A5 (https=)
US20210299141A1 (en) Benzothiazepine compounds and their use as bile acid modulators